EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: Congressional Budget Office (CBO); Federal Trade Commission (FTC); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Food & Drug Administration (FDA); White House Office; Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (HR 2190, HR 2248, S 1206) & MTM expansion (HR 891/S 274). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price (HR 905/S 733). Medicare audit restrictions (HR 4215)

Contacted: Internal Revenue Service (IRS); Government Accountability Office (GAO); Congressional Budget Office (CBO); White House Office; Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE

Bills named: H.R. 905 (112th), H.R. 4215 (112th), H.R. 891 (112th), H.R. 2248 (112th), H.R. 2190 (112th)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1409, HR 1946, HR 1839).

Contacted: Federal Trade Commission (FTC); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); White House Office; Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1839 (112th), H.R. 1946 (112th), H.R. 1409 (112th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058). FDA Safety and Innovation Act: S. 3187, H.R.3988, H.R.4087, H.R.5334, S.2236, S.2289, S.2516: issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse

Contacted: Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); SENATE; Congressional Budget Office (CBO); Federal Trade Commission (FTC); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); White House Office; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP)

Bills named: S. 2516 (112th), S. 2289 (112th), S. 27 (112th), S. 2236 (112th), S. 3187 (112th), H.R. 4087 (112th), H.R. 5334 (112th), H.R. 1971 (112th), H.R. 3988 (112th), H.R. 979 (112th)

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures FDA Safety and Innovation Act: S. 3187, H.R.3988, H.R.4087, H.R.5334, S.2236, S.2289, S.2516: issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Government Accountability Office (GAO); Food & Drug Administration (FDA); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Labor, Dept of (DOL); White House Office

Bills named: S. 3187 (112th), S. 2289 (112th), S. 2516 (112th), H.R. 4087 (112th), H.R. 3988 (112th), S. 2236 (112th), H.R. 5334 (112th)

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery: S 1789 and HR 2309

Contacted: Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Government Accountability Office (GAO); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC)

Bills named: H.R. 2309 (112th)

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012--specifically promotion of House TMOP demonstration program

Contacted: Government Accountability Office (GAO); Labor, Dept of (DOL); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO)